pulmonary hypertension and drugs Flashcards
Normal mean pulmonary pressure
10-14 mmHg
pulmonary hypertension: (value)
more than 25 mmHg at rest
pulmonary hypertension results in …. (Histology)
- arteriosclerosis 2. medial hypertrophy 3. intimal fibrosis
OF PULMONARY ARTERIES
pulmonary hypertension - course
severe respiratory distress –> cyanosis and RVH –>
death from decompensated cor pulmonale
classification group of pulmonary hypertension - number
5
classicfication group of pulmonary hypertension - based on
cause and treatment options
PH
pulmonary hypertension
which are the classicfication group of pulmonary hypertension
- pulmonary arterial hypertension (PAH)
- PH due to left heart disease
- PH due to lung disease or hypoxia
- chronic thromboembolic PH
- multifactorial PH
multifactorial pulmonary hypertensions - causes
- hematologic disorders
- systemic disorders
- metabolic disorders
chronic thromboembolic pulmonary hypertensions - pathophysiology
recurrent microthrombi –> decreased sectional area of pulmonary vascular bed
pulmonary hypertensions due to lung disease or hypoxia - pathophysiology
- destruction of lung parenchyma
2. hypoxemic vasoconstriction
pulmonary hypertensions due to lung disease or hypoxia - destruction of lung parenchyma example
COPD
pulmonary hypertensions due to lung disease or hypoxia - hypoxemic vasoconstriction
- obstructive sleep apnea
2. living in high altitude
pulmonary hypertensions due to left heart disease - is often due to
- systolic dysfunction
- diastolic dysfunction
- valvular disease such as mitral stenosis
pulmonary arterial hypertension (PAH) - idiopathic - prognosis
poor
pulmonary arterial hypertension (PAH) - causes
- idiopathic
- drugs
- connective tissue disease
- HIV infection
- portal hypertension
- congenital heart disease
- schistosomiasis
pulmonary arterial hypertension (PAH) - idiopathic - pathophysiology
often due to inactivation mitation in BMPR2 gene
BMPR2 gene - normal action
inhibits vascular SMCs proliferation
pulmonary arterial hypertension (PAH) also includes
- pulmonary venous occlusive disease
2. persistent PH of newborn
pulmonary arterial hypertension (PAH) - drugs that cause it
- amphetamines
2. cocaine
idiopathic pulmonary arterial hypertension (PAH) - special feature
heritable
pulmonary hypertension drugs - categories
- endothelin receptor antagonists
- PDE-5 inhibitors
- Prostacyclin analogs
pulmonary hypertension drugs - categories and drugs
- endothelin receptor antagonists –> BOSENTAN
- PDE-5 inhibitors –> SILDENAFIL
- Prostacyclin analogs –> EPOPROSTENOL, ILOPROST
pulmonary hypertension drugs - endothelin receptor antagonists - drug and toxicity
bosentan
hepatotoxicity
pulmonary hypertension drugs - endothelin receptor antagonists - monitor
monitor LFTs
pulmonary hypertension drugs - endothelin receptor antagonists - drug and mechanism of action
Bosentan: competitively antagonize endothelin-1 receptors –> decreases pulmonary vascular resistance
pulmonary hypertension drugs - PDE-5 inhibitors - drugs
sildenafil (viagra)
pulmonary hypertension drugs - PDE-5 inhibitors - mechanism of action
inhibit cGMP PDE5 and prolong vasodilatory effect of nitric oxide
pulmonary hypertension drugs - PDE-5 inhibitors - they also used for
erectile dysfunction
sildenafil - used for
- pulmonary hypertension
2. erectile dysfunction
prostacyclin analogs side effects
- flushing
2. jaw pain
prostacyclin analogs for pulmonary hypertension - drugs
- epoprostenol
2. iloprost
prostacyclin analogs for pulmonary hypertension - mechanism of action
prostacyclins (PGI2) with direct vasodilatory effects on pulmonary and systemic arterial vascular beds
inhibit platelet aggregation
pulmonary hypertension treatment - categories
- endothelin receptor antagonists –> BOSENTAN
- PDE-5 inhibitors –> SILDENAFIL
- Prostacyclin analogs –> EPOPROSTENOL, ILOPROST
pulmonary hypertension treatment - drug with hepatotoxicity
bosentan
hiv infection - type of pulmonary hypertension
pulmonary arterial hypertension
type of pulmonary hypertension with poor prognosis
pulmonary arterial hypertension
obstructive sleep apnea - type of pulmonary hypertension
PH due to lung disease or hypoxia
portal hypertension - type of pulmonary hypertension
pulmonary arterial hypertension
pulmonary hypertension treatment - categories
- endothelin receptor antagonists –> BOSENTAN
- PDE-5 inhibitors –> SILDENAFIL
- Prostacyclin analogs –> EPOPROSTENOL, ILOPROST